Satellite repeat RNA expression in epithelial ovarian cancer associates with a tumor-immunosuppressive phenotype Journal Article
| Authors: | Porter, R. L.; Sun, S.; Flores, M. N.; Berzolla, E.; You, E.; Phillips, I. E.; KC, N.; Desai, N.; Tai, E. C.; Szabolcs, A.; Lang, E. R.; Pankaj, A.; Raabe, M. J.; Thapar, V.; Xu, K. H.; Nieman, L. T.; Rabe, D. C.; Kolin, D. L.; Stover, E. H.; Pepin, D.; Stott, S. L.; Deshpande, V.; Liu, J. F.; Solovyov, A.; Matulonis, U. A.; Greenbaum, B. D.; Ting, D. T. |
| Article Title: | Satellite repeat RNA expression in epithelial ovarian cancer associates with a tumor-immunosuppressive phenotype |
| Abstract: | Aberrant expression of viral-like repeat elements is a common feature of epithelial cancers, and the substantial diversity of repeat species provides a distinct view of the cancer transcriptome. Repeatome profiling across ovarian, pancreatic, and colorectal cell lines identifies distinct clustering independent of tissue origin that is seen with coding gene analysis. Deeper analysis of ovarian cancer cell lines demonstrated that human satellite II (HSATII) satellite repeat expression was highly associated with epithelial-mesenchymal transition (EMT) and anticorrelated with IFN-response genes indicative of a more aggressive phenotype. SATII expression - and its correlation with EMT and anticorrelation with IFN-response genes - was also found in ovarian cancer RNA-Seq data and was associated with significantly shorter survival in a second independent cohort of patients with ovarian cancer. Repeat RNAs were enriched in tumor-derived extracellular vesicles capable of stimulating monocyte-derived macrophages, demonstrating a mechanism that alters the tumor microenvironment with these viral-like sequences. Targeting of HSATII with antisense locked nucleic acids stimulated IFN response and induced MHC I expression in ovarian cancer cell lines, highlighting a potential strategy of modulating the repeatome to reestablish antitumor cell immune surveillance. |
| Keywords: | oncology; innate immunity; noncoding rnas; cancer |
| Journal Title: | Journal of Clinical Investigation |
| Volume: | 132 |
| Issue: | 16 |
| ISSN: | 0021-9738 |
| Publisher: | American Society for Clinical Investigation |
| Date Published: | 2022-08-15 |
| Start Page: | e155931 |
| Language: | English |
| DOI: | 10.1172/jci155931 |
| PUBMED: | 35708912 |
| PROVIDER: | scopus |
| PMCID: | PMC9374379 |
| DOI/URL: | |
| Notes: | Article -- Export Date: 1 September 2022 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work